drugset / Trial / NCT01416402
Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether arhalofenate is safe and effective when dosed in combination with febuxostat in lowering serum uric acid in patients with gout.
Timeline
- Start
- 2011-08
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Arhalofenate | Unknown | 600 mg | Oral |
| Background | Colchicine | Small molecule | 0.6 mg | Oral |
| Background | Febuxostat | Small molecule | 80 mg | Oral |